Remove 2020 Remove FDA Remove Method Validation
article thumbnail

Flow cytometry: advantages in immunotherapy clinical trials

Pharmaceutical Technology

CAGR between 2020 and 2028. To ensure the quality of FCM assay performance in preclinical and clinical applications, several scientific organizations developed recommendations for FCM instrumentation and method validation.

article thumbnail

CMC Requirements for New Drug Registration in Latin America

ISPE

ANVISA’s analytical method validation 15 and forced degradation 1 requirements are examples of those local regulations that bring additional technical requirements and make a Brazil dossier different from a US or EU dossier (both ICH member countries) and drive the divergence between harmonized global registration process.

article thumbnail

Streamlining Postapproval Submissions Using ICH Q12 & SCDM

ISPE

In May 2021, the US Food and Drug Administration (FDA) published a draft industry guidance, ICH Q12: Implementation Considerations for FDA-Regulated Products. The European Medicines Agency (EMA) issued its implementation guidance in March 2020. Journal of Pharmaceutical Sciences 109 (2020):1427–1438. doi:10.1016/j.xphs.2021.09.046.